TABLE 1.

Expression of STIP1 in Relation to Clinicopathological Characteristics in IHC Analysis

	No.	%	Mean scores (95% CI)	Range	P
All study subjects	167	100	3.59 (3.10 to 4.09)	0–12
Diagnostic category					<0.001
Normal	9	5.4	0.22 (−0.12 to 0.56)	0–1
Benign	17	10.2	0.82 (0.27 to 1.38)	0–3
Borderline	15	9.0	2.53 (1.01 to 4.06)	0–9
Cancer	126	75.4	4.83 (4.28 to 5.37)	0–12
FIGO stage					0.008
I–II	34	27.0	3.62 (2.77 to 4.47)	0–8
III–IV	92	73.0	5.27 (4.60 to 5.94)	0–12
Cell type					0.584
Serous	84	66.7	4.56 (3.85 to 5.26)	0–12
Mucinous	15	11.9	4.27 (2.39 to 6.14)	0–9
Other	27	21.4	3.78 (2.54 to 5.01)	0–12
Tumor grade					0.004
Borderline	15	13.8	2.53 (1.01 to 4.06)	0–9
Well	11	10.1	4.09 (2.35 to 5.83)	1–8
Moderate	44	40.3	5.18 (4.16 to 6.20)	0–12
Poor	39	35.8	5.87 (4.94 to 6.80)	1–12
CA125					0.814
Negative	17	13.5	4.53 (2.67 to 6.39)	0–12
Positive (>35 U/mL)	109	86.5	4.33 (3.73 to 4.93)	0–12
Chemosensitivity					0.920
Sensitive	72	71.2	4.63 (3.84 to 5.41)	0–12
Resistant	29	28.8	4.55 (3.35 to 5.76)	0–12